Skip to content

Clinical trials

Acromegaly trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acromegaly Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20111
20142
20151
20171
20201
20211
20221
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status3
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.2
Huashan Hospital2
Ipsen2
Crinetics Pharmaceuticals Inc.1
Ginkgo Leaf Center for Rare Disorders1
Shanghai Jiao Tong University School of Medicine1
Triastek (Shanghai) Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acromegaly13
Pituitary Neoplasms2
Cardiomyopathies1
Gigantism1
Growth Disorders1
Hyperglycemia1
Pituitary ACTH Hypersecretion1

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.